首页> 外文期刊>Human Genetics >Common variation in KLKB1 and essential hypertension risk: tagging-SNP haplotype analysis in a case-control study.
【24h】

Common variation in KLKB1 and essential hypertension risk: tagging-SNP haplotype analysis in a case-control study.

机译:KLKB1的常见变异和原发性高血压风险:病例对照研究中的SNP单倍型标签分析。

获取原文
获取原文并翻译 | 示例
       

摘要

The human plasma kallikrein gene (KLKB1) encodes plasma kallikrein, a serine protease that catalyzes the release of kinins and other vasoactive peptides and may be involved in the pathogenesis of hypertension. In this study, we performed a haplotype-based study to assess the effect of common genetic variation in the KLKB1 gene on the risk of essential hypertension. Eight common single nucleotide polymorphisms (SNPs) were selected from the HapMap database and used to determine the pattern of linkage disequilibrium (LD) and haplotype structure within the KLKB1 gene. Four tag SNPs were then identified with over 85% power to predict both common haplotypes and remaining common SNPs, and genotyped in 1,317 cases with essential hypertension and 1,269 healthy controls. Single SNP analyses indicated that SNPs rs2304595 and rs4253325 were significantly associated with hypertension, adjusted for covariates. Compared with the most common Hap2 CAGC, Hap1 AGAC and Hap3 CGAC, which carry the susceptible rs2304595 G allele and rs4253325 A allele, were found to significantly increase the risk of essential hypertension with adjusted odds ratios equal to 1.37 and 1.17, respectively (P < 0.0001 and 0.028). A strongly significant interaction with gene-drinking was also observed. Among drinkers, the adjusted OR for Hap1 relative to Hap2 was increased to 2.50 (95% CI, 2.40 to 2.61; P < 0.0001). This was the first study to perform association analysis of the KLKB1 gene with essential hypertension. Our findings suggested that common genetic variation in the KLKB1 gene might contribute to the risk of hypertension in the northern Han Chinese population.
机译:人血浆激肽释放酶基因(KLKB1)编码血浆激肽释放酶,这是一种丝氨酸蛋白酶,可催化激肽和其他血管活性肽的释放,并可能参与高血压的发病机制。在这项研究中,我们进行了基于单倍型的研究,以评估KLKB1基因常见遗传变异对原发性高血压风险的影响。从HapMap数据库中选择了八个常见的单核苷酸多态性(SNP),并用于确定KLKB1基因内的连锁不平衡(LD)模式和单倍型结构。然后鉴定出四个标签SNP,具有超过85%的功效,可预测常见的单倍型和剩余的常见SNP,并在1,317例原发性高血压病例和1,269例健康对照者中进行了基因分型。单个SNP分析表明,经协变量调整后,SNP rs2304595和rs4253325与高血压显着相关。与最常见的Hap2 CAGC相比,携带易感性rs2304595 G等位基因和rs4253325 A等位基因的Hap1 AGAC和Hap3 CGAC被发现可显着增加原发性高血压的风险,调整后的优势比分别为1.37和1.17(P < 0.0001和0.028)。还观察到与基因饮用的强​​烈相互作用。在饮酒者中,相对于Hap2,Hap1的调整后OR升高至2.50(95%CI,2.40至2.61; P <0.0001)。这是第一项对KLKB1基因与原发性高血压进行关联分析的研究。我们的研究结果表明,KLKB1基因的常见遗传变异可能会导致北方汉族人群患高血压的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号